Respiratory Review of 2013: Pulmonary Thromboembolism
- Authors
- Hwang, Hun Gyu; Schulman, Sam
- Issue Date
- Sep-2013
- Publisher
- 대한결핵및호흡기학회
- Keywords
- Pulmonary Embolism; Anticoagulants
- Citation
- Tuberculosis and Respiratory Diseases, v.75, no.3, pp 89 - 94
- Pages
- 6
- Journal Title
- Tuberculosis and Respiratory Diseases
- Volume
- 75
- Number
- 3
- Start Page
- 89
- End Page
- 94
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/13403
- DOI
- 10.4046/trd.2013.75.3.89
- ISSN
- 1738-3536
2005-6184
- Abstract
- Pulmonary embolism (PE), which can originate as a consequence of deep vein thrombosis (DVT), is the most frequent and potentially fatal venous thromboembolic event. Despite the fact that the incidence of venous thromboembolism (VTE) in Asians is lower than that in the Western populations, a recent epidemiologic study demonstrates an increasing incidence of VTE in the Korean population. Anticoagulants, including low molecular weight heparin (LMWH) and vitamin K antagonist (VKAs), have been the main treatments for PE, however, recently new oral anticoagulants (NOACs) were introduced. We will review how well patients with PE can be managed with the existing anticoagulants and NOACs along with the time span of treatment, which still pose some challenges for clinicians.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Internal Medicine > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/13403)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.